Global Healthcare Contract Development and Manufacturing Organization (CDMO) Market 2020-2026
在預測期內，估計全球醫療保健發展與製造組織（CDMO）市場將顯著增長。市場增長受到許多因素的驅動，其中包括主要由製藥和醫療設備公司採用的合同製造和合同開發服務的增加。生物製藥生產商在研發上投入了大量資金，這為製藥生產能力留下了很大的空間。此外，據報導，製藥公司與API合同製造商之間建立了合作關係。例如，2018年1月，阿斯利康（AstraZeneca PLC）與小型通用API製造商和分子創新者Cambrex Corp.簽署了一項長期供應協議。根據合同，Cambrex將為阿斯利康提供定制的API合同製造服務。此外，由於製藥公司在遵守嚴格的政府法規方面承受的壓力越來越大，因此，製藥生產正在鼓勵製藥行業對外包服務的需求，以推動市場的進一步增長。
Global Healthcare Contract Development And Manufacturing Organization (CDMO) Market Size, Share & Trends Analysis Report by Services (Contract Development and Contract Manufacturing) and Forecast 2020-2026
The global healthcare CDMO market is estimated to grow significantly during the forecast period. The market growth mainly backed by the various factors such as growing adoption of contract manufacturing and contract development services by the pharmaceutical and medical device companies. As biopharmaceutical companies are significantly investing in R&D, there is a significant scope for manufacturing capacity for pharmaceutical products.Further, the partnerships among pharmaceutical companies and API contract manufacturers were reported. For instance, in January 2018, AstraZeneca PLC entered into a long-term supply agreement with Cambrex Corp., a small generic API manufacturer and molecule innovator. As per the the agreement, Cambrex would provide customized API contract manufacturing services to AstraZeneca. Moreover, with the growing pressure over pharmaceutical companies to meet the stringent government regulation while the pharmaceuticals production is encouraging the demand for outsourcing services in pharmaceutical industry that further propels the market growth.
The global market for healthcare CDMO is segregated on the basis of services and region. Based on services, the market is further classified into contract development and contract manufacturing. The contract manufacturing services segment I projected to have significant share in the global healthcare CDMO market owing to the significant adoption of outsourcing servies by the pharmaceutical companies across the globe. Based on geography, the global healthcare CDMO market is further segregated into North America, Europe, Asia-Pacific and the Rest of the World. Among, region North America projected to have a considerable share in the global healthcare CDMO market owing to presence of major market players and significant investment in drug discovery and development in the region.
The companies which are contributing to the growth of the global healthcare CDMO market include Catalent, Inc., Lonza Group Ltd., Boehringer Ingelheim International GmbH, Pfizer Inc., Thermo Fisher Scientific Inc., and others. Product launch, merger, and acquisition, collaborations with government, and technological advancements through which market players are considerably contributing to the market growth to stay competitive in the market.
The market study of the global healthcare CDMO market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include:
The report is intended for pharmaceutical and medical devices companies for overall market analysis, and competitive analysis. The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.
The Report Covers: